Executive Summary: CDDF Annual Conference 2026 – “Cancer Clinical Research in a Changing Global Environment” (9-11 Feb 2026)
The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of this year’s Annual Conference has been published today and is available to all our stakeholders. This multi-stakeholder conference took place on 9-11 February 2026 in...
ACT EU: MSP AG – Call for Expressions of Interest
📢 🔔Take a look at the below ‘Call for Expressions of Interest’ from the Multi-stakeholder Platform Advisory Group (MSP AG) under ACT EU: ▶️ Message from ACT EU: MSP AG “Call for Expression of Interest – Focus Group on the review of the Guideline for...
[NEW PUBLICATION: WHITE PAPER – Innovative Oncology Trial Designs: Time to Act]
While the CDDF Annual Conference 2026 is in full swing, we are thrilled to announce the publication of our latest white paper: “Innovative oncology trial designs: Time to act – A review with recommendations of the Cancer Drug Development Forum.” This paper was largely...